Access to Medicines as a Human Right : : Implications for Pharmaceutical Industry Responsibility / / Lisa Forman, Jillian Clare Kohler.

According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the pr...

Full description

Saved in:
Bibliographic Details
VerfasserIn:
MitwirkendeR:
Place / Publishing House:Toronto : : University of Toronto Press, , [2018]
©2012
Year of Publication:2018
Language:English
Online Access:
Physical Description:1 online resource (240 p.) :; 3 tables
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • Frontmatter
  • Contents
  • Acknowledgments
  • 1.Introduction: Access to Medicines as a Human Right - What Does It Mean for Pharmaceutical Industry Responsibilities?
  • PART ONE. Rights, Norms, and Ethics
  • 2. Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines
  • 3. Improving Access to Essential Medicines: International Law and Normative Change
  • 4. Corporate Social Responsibility and the Right to Essential Medicines
  • PART TWO. Social versus Business Responsibilities
  • 5. Benchmarking and Transparency: Incentives for the Pharmaceutical Industry's Corporate Social Responsibility
  • 6. Social Responsibility and Marketing of Drugs in Developing Countries: A Goal or an Oxymoron?
  • PART THREE. Case Studies for Achieving Corporate Responsibility
  • 7. Managing the Market for Medicines Access: Realizing the Right to Health by Facilitating Compulsory Licensing of Pharmaceuticals - A Case Study of Legislation and the Need for Reform
  • 8. Ubuntu, AIDS, and the King II Report: Reflections on Corporate Social Responsibility in South Africa
  • Annex: Human Rights Guidelines for Pharmaceutical Companies in Relation to Access to Medicines
  • Contributors